Literature DB >> 27787501

The need for a next-generation public health response to rare diseases.

Rodolfo Valdez1, Scott D Grosse1, Muin J Khoury2.   

Abstract

Entities:  

Mesh:

Year:  2016        PMID: 27787501      PMCID: PMC5547019          DOI: 10.1038/gim.2016.166

Source DB:  PubMed          Journal:  Genet Med        ISSN: 1098-3600            Impact factor:   8.822


× No keyword cloud information.
  10 in total

1.  A public health framework for rare blood disorders.

Authors:  Scott D Grosse; Andra H James; Michele A Lloyd-Puryear; Hani K Atrash
Journal:  Am J Prev Med       Date:  2011-12       Impact factor: 5.043

Review 2.  National plans and strategies on rare diseases in Europe.

Authors:  Domenica Taruscio; Luciano Vittozzi; Rumen Stefanov
Journal:  Adv Exp Med Biol       Date:  2010       Impact factor: 2.622

3.  From public health emergency to public health service: the implications of evolving criteria for newborn screening panels.

Authors:  Scott D Grosse; Coleen A Boyle; Aileen Kenneson; Muin J Khoury; Benjamin S Wilfond
Journal:  Pediatrics       Date:  2006-03       Impact factor: 7.124

Review 4.  Advocacy groups and their role in rare diseases research.

Authors:  Mary Dunkle; Wayne Pines; Peter L Saltonstall
Journal:  Adv Exp Med Biol       Date:  2010       Impact factor: 2.622

5.  Contribution of birth defects and genetic diseases to pediatric hospitalizations. A population-based study.

Authors:  P W Yoon; R S Olney; M J Khoury; W M Sappenfield; G F Chavez; D Taylor
Journal:  Arch Pediatr Adolesc Med       Date:  1997-11

6.  The NIH Undiagnosed Diseases Program and Network: Applications to modern medicine.

Authors:  William A Gahl; John J Mulvihill; Camilo Toro; Thomas C Markello; Anastasia L Wise; Rachel B Ramoni; David R Adams; Cynthia J Tifft
Journal:  Mol Genet Metab       Date:  2016-01-22       Impact factor: 4.797

7.  Analysis of protein-coding genetic variation in 60,706 humans.

Authors:  Monkol Lek; Konrad J Karczewski; Eric V Minikel; Kaitlin E Samocha; Eric Banks; Timothy Fennell; Anne H O'Donnell-Luria; James S Ware; Andrew J Hill; Beryl B Cummings; Taru Tukiainen; Daniel P Birnbaum; Jack A Kosmicki; Laramie E Duncan; Karol Estrada; Fengmei Zhao; James Zou; Emma Pierce-Hoffman; Joanne Berghout; David N Cooper; Nicole Deflaux; Mark DePristo; Ron Do; Jason Flannick; Menachem Fromer; Laura Gauthier; Jackie Goldstein; Namrata Gupta; Daniel Howrigan; Adam Kiezun; Mitja I Kurki; Ami Levy Moonshine; Pradeep Natarajan; Lorena Orozco; Gina M Peloso; Ryan Poplin; Manuel A Rivas; Valentin Ruano-Rubio; Samuel A Rose; Douglas M Ruderfer; Khalid Shakir; Peter D Stenson; Christine Stevens; Brett P Thomas; Grace Tiao; Maria T Tusie-Luna; Ben Weisburd; Hong-Hee Won; Dongmei Yu; David M Altshuler; Diego Ardissino; Michael Boehnke; John Danesh; Stacey Donnelly; Roberto Elosua; Jose C Florez; Stacey B Gabriel; Gad Getz; Stephen J Glatt; Christina M Hultman; Sekar Kathiresan; Markku Laakso; Steven McCarroll; Mark I McCarthy; Dermot McGovern; Ruth McPherson; Benjamin M Neale; Aarno Palotie; Shaun M Purcell; Danish Saleheen; Jeremiah M Scharf; Pamela Sklar; Patrick F Sullivan; Jaakko Tuomilehto; Ming T Tsuang; Hugh C Watkins; James G Wilson; Mark J Daly; Daniel G MacArthur
Journal:  Nature       Date:  2016-08-18       Impact factor: 49.962

Review 8.  Access to Orphan Drugs: A Comprehensive Review of Legislations, Regulations and Policies in 35 Countries.

Authors:  Todd Gammie; Christine Y Lu; Zaheer Ud-Din Babar
Journal:  PLoS One       Date:  2015-10-09       Impact factor: 3.240

9.  Public Health and Rare Diseases: Oxymoron No More.

Authors:  Rodolfo Valdez; Lijing Ouyang; Julie Bolen
Journal:  Prev Chronic Dis       Date:  2016-01-14       Impact factor: 2.830

10.  The collective impact of rare diseases in Western Australia: an estimate using a population-based cohort.

Authors:  Caroline E Walker; Trinity Mahede; Geoff Davis; Laura J Miller; Jennifer Girschik; Kate Brameld; Wenxing Sun; Ana Rath; Ségolène Aymé; Stephen R Zubrick; Gareth S Baynam; Caron Molster; Hugh J S Dawkins; Tarun S Weeramanthri
Journal:  Genet Med       Date:  2016-09-22       Impact factor: 8.822

  10 in total
  8 in total

1.  30-day all-cause readmission rates among a cohort of individuals with rare conditions.

Authors:  Kevin J Bennett; Joshua R Mann; Lijing Ouyang
Journal:  Disabil Health J       Date:  2018-09-12       Impact factor: 2.554

2.  Clinical application of whole-exome sequencing: A retrospective, single-center study.

Authors:  Qiang Zhang; Zailong Qin; Shang Yi; Hao Wei; Xun Zhao Zhou; Jiasun Su
Journal:  Exp Ther Med       Date:  2021-05-12       Impact factor: 2.447

3.  Validation of intellectual disability coding through hospital morbidity records using an intellectual disability population-based database in Western Australia.

Authors:  Jenny Bourke; Kingsley Wong; Helen Leonard
Journal:  BMJ Open       Date:  2018-01-23       Impact factor: 2.692

4.  Expert Evaluation of Strategies to Modernize Newborn Screening in the United States.

Authors:  Donald B Bailey; Katherine Ackerman Porter; Sara M Andrews; Melissa Raspa; Angela Y Gwaltney; Holly L Peay
Journal:  JAMA Netw Open       Date:  2021-12-01

5.  Treating rare diseases with the cinema: Can popular movies enhance public understanding of rare diseases?

Authors:  Jan Domaradzki
Journal:  Orphanet J Rare Dis       Date:  2022-03-05       Impact factor: 4.123

6.  Maximal Segmental Score Method for Localizing Recessive Disease Variants Based on Sequence Data.

Authors:  Ai-Ru Hsieh; Jia Jyun Sie; Chien Ching Chang; Jurg Ott; Ie-Bin Lian; Cathy S J Fann
Journal:  Front Genet       Date:  2020-06-12       Impact factor: 4.599

7.  A retrospective review of the contribution of rare diseases to paediatric mortality in Ireland.

Authors:  Emer Gunne; Cliona McGarvey; Karina Hamilton; Eileen Treacy; Deborah M Lambert; Sally Ann Lynch
Journal:  Orphanet J Rare Dis       Date:  2020-11-04       Impact factor: 4.123

Review 8.  From public health genomics to precision public health: a 20-year journey.

Authors:  Muin J Khoury; M Scott Bowen; Mindy Clyne; W David Dotson; Marta L Gwinn; Ridgely Fisk Green; Katherine Kolor; Juan L Rodriguez; Anja Wulf; Wei Yu
Journal:  Genet Med       Date:  2017-12-14       Impact factor: 8.822

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.